JPRN-UMIN000025878已完成2 期
Phase II trial of nivolumab following radiation therapy to bone metastases in patients with non-small cell lung cancer - RT-Nivo NSCLC phase II
niversity of Tsukuba Hospital0 个研究点目标入组 30 人开始时间: 2017年2月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Positive for epidermal grow factor receptor activating mutation or ALK re-arrangement 2) Active malignancies within 2 years 3) Active infection requiring intravenous systemic therapy or hospital admission 4) A history of interstitial lung disease 5) A history of active, known autoimmune disease. 6) Requiring systemic treatment with either corticosteroids (>10 mg daily prednisone equivalent) or other immunosuppressive medications. 7) Active CNS metastasis 8) Carcinomatous meningitis 9) Positive for HBs antigen or HBV-DNA positive 10) Positive for HCV antibody 11) Pregnant or breast-feeding women 12) Any other patients whom the doctor judged to be unsuitable for this trial
研究者
相似试验
进行中（未招募）
1 期
Trial evaluating the tolerance and safety of durvalumab - radiotherapy combination for treatment of cancers of the head and neckntreated Squamous cell carcinoma : Oral cavity, oropharynx, hypopharynx or larynxMedDRA version: 20.0Level: PTClassification code 10060121Term: Squamous cell carcinoma of head and neckSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2018-001976-39-FRGORTEC73
进行中（未招募）
1 期
Trial evaluating the tolerance and safety of durvalumab - radiotherapy combination for treatment of cancers of the head and neckntreated squamous cell carcinoma of the head and neckMedDRA version: 26.1Level: PTClassification code: 10060121Term: Squamous cell carcinoma of head and neck Class: 100000004864CTIS2024-513977-31-00Groupe Oncologie Radiotherapie Tete Cou61
进行中（未招募）
1 期
Treatment of advanced lung cancerPatients with locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) and patients with Small cell lung cancer (SCLC) after failure of platinum-based first-line therapy.MedDRA version: 21.1Level: PTClassification code 10029522Term: Non-small cell lung cancer stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.1Level: PTClassification code 10041068Term: Small cell lung cancer extensive stageSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.1Level: PTClassification code 10029521Term: Non-small cell lung cancer stage IIIBSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.1Level: PTClassification code 10059515Term: Non-small cell lung cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.1Level: PTClassification code 10029515Term: Non-small cell lung cancer recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.1Level: PTClassification code 10041070Term: Small cell lung cancer recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.1Level: PTClassification code 10059514Term: Small cell lung cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2016-003334-25-DEniversity of Cologne90
进行中（未招募）
1 期
Nivolumab and Radiation Therapy With or Without Ipilimumab in Treating Patients With Brain Metastases From Non-small Cell Lung CancerMetastatic Malignant Neoplasm in the BrainStage IV Non-Small Cell Lung Cancer AJCC v7NCT02696993M.D. Anderson Cancer Center80
进行中（未招募）
1 期
A study of nivolumab in participants with metastatic or unresectable bladder cancermetastatic or unresectable urothelial cancerMedDRA version: 19.0Level: LLTClassification code 10046723Term: Urothelial carcinoma ureterSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.0Level: LLTClassification code 10046714Term: Urothelial carcinoma bladderSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.0Level: LLTClassification code 10064467Term: Urothelial carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.0Level: PTClassification code 10005003Term: Bladder cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.0Level: LLTClassification code 10046728Term: Urothelial carcinoma urethraSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2014-003625-17-SEBristol-Myers Squibb International Corporation323